Home › Studies › PRJNA1181778
PRJNA1181778 SRP543000

Gut microbiome, synbiotic SIM01 trial, Hong Kong vaccinees

The Immune Microbiome Product Against COVID infecTion (IMPACT) study

560 stool samples from Hong Kong vaccinees (elderly and diabetic) receiving SARS-CoV-2 vaccination, studying SIM01 synbiotic (three Bifidobacterium strains) versus placebo in an intervention design with baseline and postvaccination timepoints. machine-written summary

560 samples · 560 runs · HK · Age unknown · 2025 · 5.36 Gbp / sample

Sources
✓Sequence archive 1,680○Abstract / description✓Full text 1,680○Supplementary tables–External resources–User contribution–Human verified

Checked this project's papers and archive records yourself? Mark it human-verified.

what each source gave
✓ Sequence archive1,680 sample values (country, latitude, longitude)
○ Abstract / descriptionread; no usable statement
✓ Full text1,680 sample values (collection date, health condition, health condition detail) · PMC12375777
○ Supplementary tablesfiles read; no table could be matched to the samples
– External resourcesnot covered by the external resources we ingest
– User contributionnothing uploaded yet · share metadata
– Human verifiednot yet checked by a person · I checked this project — verify it
Interventions

intervention — arms not resolved

Synbiotic (probiotic + prebiotic) design randomized_controlled_trial · SIM01 synbiotic (3 Bifidobacterium strains) vs placebo, 3 months post-vaccination

“received 3 months of SIM01” — abstract:40851072 (study level; per-sample arms are in the intervention column below)

Samples at a glance
1 sampling locations · 1 country
Age
unknown560
Condition
intervention_cohort560
Country
HK560
Body site
primary560
Sequencing depth per sample · this project all projects
all projects, 0–0.03 Gbp: 25,080 samples (4 %)all projects, 0.03–0.1 Gbp: 17,066 samples (3 %)all projects, 0.1–0.3 Gbp: 29,179 samples (5 %)all projects, 0.3–1 Gbp: 47,044 samples (8 %)all projects, 1–3 Gbp: 124,983 samples (22 %)this project, 1–3 Gbp: 5 samplesall projects, 3–10 Gbp: 253,728 samples (44 %)this project, 3–10 Gbp: 538 samplesall projects, 10–30 Gbp: 72,533 samples (13 %)this project, 10–30 Gbp: 15 samplesall projects, 30–100 Gbp: 3,024 samples (1 %)this project, 30–100 Gbp: 2 samplesall projects, 100–300 Gbp: 106 samples (0 %)all projects, ≥ 300 Gbp: 9 samples (0 %)project median 5.36 Gbp per sample0130Gbp
Sampling design and relatedness

longitudinal — not resolved

How longitudinal and relatedness information is derived

Community composition
Bacteroides 11.6%Phocaeicola 9.5%Prevotella 6.4%Blautia_A 4.3%Roseburia 3.9%Faecalibacterium 3.8%Lachnospira 3.1%Gemmiger 2.8%Alistipes 2.6%Bifidobacterium 2.4%Escherichia 1.6%Vescimonas 1.6%not assigned to a genus 4.0%other genera 42.5%

Genera, mean relative abundance over 549 profiled gut samples of this project (Sandpiper SingleM profiles, GTDB R232; low-depth and non-metagenome profiles left out).

Field coverage
fieldsamplescoverageR1R2R3R4
age_category0 0%
country560 100%560
health_condition560 100%560
subject_id0 0%
collection_date560 100%560
health_condition_detail560 100%560
latitude560 100%560
longitude560 100%560
Papers (1)
  • The resident gut microbiome modulates the effect of synbiotics on the immunogenicity after SARS-COV-2 vaccination in elderly and diabetes patients. 2025 PMID 40851072 PMC12375777 own_data
Details
Archive description

Modulation of Gut Microbiota to Enhance Health and Immunity of Vulnerable Individuals During COVID-19 Pandemic

How this project entered the registry

Classified as human gut / stool shotgun DNA metagenome of age unknown by sonnet_x2 with confidence 0.62. Assay shotgun_dna.

  • host run.host_tax_id · “9606”
  • body site run.scientific_name · “human gut metagenome”
Evidence examples (one per field × route)
samplefieldvaluerouteconf.sourcequote
SAMN44568956collection_date2021-04/2022-03R30.70paper.fulltext.methodsgeneral population of Hong Kong from April 2021 to March 2022
SAMN44568956countryHKR10.90sample.attr.geo_loc_nameHong Kong
SAMN44568956health_conditionintervention_cohortR30.70paper.fulltext.abstractreceived a gut microbiota-derived synbiotic formula (SIM01) or placebo
SAMN44568956health_condition_detailvulnerable individuals (elderly or T2DM) receiving synbiotic vs placebo post COVID-19 vaccinationR30.70paper.fulltext.abstractreceived a gut microbiota-derived synbiotic formula (SIM01) or placebo
SAMN44568956latitude22.1500R10.90biosample.attribute:lat_lon22.15 N 114.1001 E
SAMN44568956longitude114.1001R10.90biosample.attribute:lat_lon22.15 N 114.1001 E
Sequencing

560 runs over 560 samples · mean 5.96 Gbp per run (median 5.36 Gbp, total 3,338.80 Gbp; 560 runs with a base count) · layout PAIRED 560 · platform ILLUMINA 560 · models Illumina NovaSeq 6000 (560) · 98% of runs with a Sandpiper profile · first public 2025-08-26

Authors (15)

Zhang L first · Wang S · Wong MCS · Mok CKP · Ching JYL · Mak JWY · Chen C · Huo B · Yan S · Cheung CP · Chiu EOL · Fung EYT · Cheong PK · Chan FKL · Ng SC last

Help complete this project

2 of the 4 core fields are below 50% coverage: age_category, subject_id. Share metadata

Downloads

PRJNA1181778.csv.gz (14.7 KB) · parquet (95.2 KB) — all 560 samples, every field with route and confidence · PRJNA1181778_determinations.csv.gz (21.4 KB) — 3,360 evidence rows

Samples (560 · every field this project has values for · hover a cell for its source)
Loading the sample table…